HEPARIN SOD AND 0.9% SOD CHLORIDE INJ 2 UNIT
HEPARIN (HEPARIN SODIUM) : 2 UNIT SODIUM CHLORIDE : 9 MG · DIN 00828750 · BAXTER CORPORATION
Health Canada status: MARKETED
What is HEPARIN SOD AND 0.9% SOD CHLORIDE INJ?
HEPARIN SOD AND 0.9% SOD CHLORIDE INJ 2 UNIT contains HEPARIN (HEPARIN SODIUM) : 2 UNIT SODIUM CHLORIDE : 9 MG. It is listed in the Health Canada Drug Product Database under DIN 00828750, held by BAXTER CORPORATION, supplied as SOLUTION for INTRAVENOUS administration. Health Canada currently lists it as marketed, status dated 31-Dec-1990. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 00828750 |
|---|---|
| Brand name | HEPARIN SOD AND 0.9% SOD CHLORIDE INJ |
| Generic / active ingredient | HEPARIN (HEPARIN SODIUM) : 2 UNIT SODIUM CHLORIDE : 9 MG |
| Manufacturer | BAXTER CORPORATION |
| Strength | 2 UNIT |
| Dosage form | SOLUTION |
| Route of administration | INTRAVENOUS |
| Schedule | Ethical |
| ATC code | B01AB51 HEPARIN, COMBINATIONS |
| AHFS class | 20:12.04.16 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 31-Dec-1990 |
| Original market date | 1990-12-31 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code B01AB51 HEPARIN, COMBINATIONS. 4 of 8 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| HEPARIN SODIUM 20000UNITS IN 5% DEXTROSE INJ | 4000 UNIT / 100 ML | SOLUTION | B. BRAUN MEDICAL INC | MARKETED | DIN 02209713 |
| HEPARIN SODIUM 25000UNITS IN 5% DEXTROSE INJ | 5 G / 100 ML | SOLUTION | B. BRAUN MEDICAL INC | MARKETED | DIN 02209721 |
| HEPARIN SODIUM IN 5% DEXTROSE INJECTION, 25000UNIT/500ML | 5 G / 100 ML | SOLUTION | B. BRAUN MEDICAL INC | MARKETED | DIN 01935941 |
| HEPARIN SODIUM & 5% DEXTROSE INJECTION LIQ | 5 G / 100 ML | SOLUTION | BAXTER CORPORATION | CANCELLED POST MARKET | DIN 02008181 |
| HEPARIN SODIUM & DEXTROSE 5% IN VIAFLEX LIQ | 5 G / 100 ML | SOLUTION | BAXTER CORPORATION | CANCELLED POST MARKET | DIN 01900757 |
| HEPARIN SODIUM AND DEXTROSE 5% INJ USP | 5 G / 100 ML | LIQUID | BAXTER CORPORATION | CANCELLED POST MARKET | DIN 01913255 |
| HEPARIN SODIUM IN 0.9% SODIUM CHLORIDE INJECTION | 430 MG / 100 ML | SOLUTION | B. BRAUN MEDICAL INC | DORMANT | DIN 01935933 |
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.